Examkin

All practice questions

4736 questions

All types4,736Multiple choice2,413Multiple select567Numeric127Matching858Ordering771
Question 2861Question →

A 68-year-old male with highly symptomatic paroxysmal atrial fibrillation is scheduled to begin amiodarone therapy for rhythm control. He has a history of hypertension, type 2 diabetes mellitus, and chronic kidney disease stage 3. His current medications include lisinopril, metformin, and apixaban. He has no history of pulmonary disease. Which of the following baseline laboratory or diagnostic parameters are essential to obtain prior to initiating amiodarone therapy? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Thyroid-stimulating hormone level; Hepatic transaminases

Answer

The essential baseline monitoring parameters prior to starting amiodarone are a thyroid-stimulating hormone (TSH) level and hepatic transaminases.
Amiodarone is a highly effective antiarrhythmic agent but is associated with significant long-term toxicities. Because it contains iodine and structurally resembles thyroid hormone, it frequently causes either hypothyroidism or hyperthyroidism; thus, a baseline thyroid-stimulating hormone (TSH) level is mandatory, along with ongoing monitoring. Additionally, amiodarone can cause hepatotoxicity ranging from asymptomatic elevated liver enzymes to severe cirrhosis. Baseline and periodic monitoring of hepatic transaminases is therefore an essential component of patient management when initiating this drug.

Step-by-Step Solution

1
Identify the primary pharmacological agent being initiated and its well-known toxicity profile.
The patient is starting amiodarone, a Class III antiarrhythmic known for multiorgan toxicity, including thyroid, liver, lung, and ocular effects.
Recognizing the adverse effect profile dictates the required baseline screening.
2
Determine the standard baseline testing recommended before starting this medication.
Standard baseline testing includes an ECG, thyroid function tests, liver function tests, and a chest radiograph (often with pulmonary function tests).
Establishing baseline values is critical to detect future organ dysfunction caused by the drug.
3
Evaluate the distractors related to the patient's current medication list, specifically apixaban.
Apixaban does not require routine coagulation monitoring or serum drug level measurements, despite a known pharmacokinetic interaction with amiodarone.
Direct oral anticoagulants have predictable pharmacokinetics and do not require the intensive monitoring seen with warfarin.

Key Concept

Amiodarone requires comprehensive baseline and ongoing monitoring, including thyroid function (TSH) and hepatic transaminases, due to its high risk of multiorgan toxicity.
Question 2862Question →

A clinical task force is revising institutional guidelines for diagnostic testing. They are analyzing how adjusting assay thresholds and applying tests in different clinical settings (such as specialized tertiary care versus community screening) affect test performance metrics. Match each strategic adjustment to its expected direct impact on the diagnostic test's performance characteristics.

Click a left item, then click its matching right item

Items

Increasing the cutoff threshold required for a positive test result on a quantitative assay
Decreasing the cutoff threshold required for a positive test result on a quantitative assay
Implementing the test in a high-risk specialty clinic where the disease is more common
Implementing the test as a universal screening tool in an asymptomatic general population where the disease is rare

Matches

Show answer & explanation

Answer

Adjusting cutoffs inversely alters intrinsic test properties (sensitivity and specificity), while applying the test to populations with different disease prevalence strictly alters predictive values (PPV and NPV).
Diagnostic tests have intrinsic properties (sensitivity and specificity) that change inversely when the diagnostic cutoff threshold is moved. Predictive values (PPV and NPV) depend on both the test's intrinsic properties and the prevalence of the disease in the tested population. Therefore, shifting a cutoff affects both intrinsic and predictive metrics, whereas shifting the population (prevalence) strictly affects predictive values.

Step-by-Step Solution

1
Analyze the effect of changing cutoff thresholds on intrinsic properties.
Raising the cutoff increases specificity and decreases sensitivity; lowering the cutoff increases sensitivity and decreases specificity.
Stricter criteria yield fewer false positives (higher specificity) but more false negatives (lower sensitivity), while looser criteria do the opposite.
2
Analyze the effect of changing population prevalence on predictive values.
Higher prevalence increases PPV and decreases NPV; lower prevalence decreases PPV and increases NPV.
Predictive values are highly dependent on the pre-test probability (prevalence) of the disease, whereas intrinsic test properties are independent of prevalence.

Key Concept

The relationship between diagnostic cutoff thresholds, disease prevalence, sensitivity, specificity, and predictive values.
Estimated Time:1m 30s
Question 2863Question →

An outpatient internal medicine clinic initiates a quality improvement project to increase the completion rate of annual diabetic foot examinations. The project committee proposes placing brightly colored reminder placards on the doors of examination rooms. To evaluate this intervention, they pilot the placards in a single provider's hallway for three consecutive days. After the trial period, the clinic manager reviews the compliance data and gathers feedback from the clinical staff. The review reveals that the placards were frequently overlooked because they visually blended in with existing infection control signage. Based on these findings, the committee determines that the intervention was ineffective in its current form. They decide to completely abandon the placard concept and instead propose integrating a mandatory reminder into the nursing intake electronic health record template for the following week.

The committee's decision to abandon the initial intervention and formulate an alternative approach corresponds to which phase of the utilized quality improvement cycle?

Show answer & explanation

Answer: Act

Answer

Act
The Plan-Do-Study-Act (PDSA) cycle is a four-step model for carrying out change. In the 'Act' phase, the quality improvement team determines the next steps based on what was learned during the 'Study' phase. The three potential decisions in the 'Act' phase are to Adopt (if the test was successful), Adapt (if the test needs modifications), or Abandon (if the test failed). Because the committee decided the placards were ineffective and chose to abandon them in favor of a new electronic template reminder, they are executing the 'Act' phase.

Step-by-Step Solution

1
Identify the quality improvement methodology being utilized in the clinical scenario.
The scenario describes small-scale, iterative testing of an intervention, which is characteristic of the Plan-Do-Study-Act (PDSA) cycle used in the Model for Improvement.
Correctly identifying the framework is necessary to correctly map the described actions to the appropriate phase.
2
Map the chronological events in the scenario to the four phases of the PDSA cycle.
Proposing the placards = Plan; Piloting for three days = Do; Reviewing data and feedback = Study; Deciding to abandon the placards = Act.
Breaking down the project timeline ensures accurate identification of the current phase in question.
3
Determine the corresponding phase for the final action described in the prompt.
The final action is the decision to abandon the ineffective intervention and formulate a new one. This corresponds directly to the 'Act' phase, where teams decide to adopt, adapt, or abandon the change.
This directly answers the prompt's question.

Key Concept

Plan-Do-Study-Act (PDSA) Cycle Phases
Question 2864Question →

Discharge planning is underway for a 72-year-old man who has been hospitalized for 8 days due to acute lower extremity weakness and severe back pain. Magnetic resonance imaging of the spine revealed a pathological fracture at T10 causing spinal cord compression. A subsequent biopsy confirmed metastatic non-small cell lung cancer. The patient underwent palliative radiotherapy and completed a course of high-dose dexamethasone.

Currently, the patient has irreversible paraplegia with absent sensation below the umbilicus. He requires a chronic indwelling urinary catheter. He is hemodynamically stable, and his pain is well-controlled on a scheduled oral morphine regimen. He requires total physical assistance for all activities of daily living, including feeding, bathing, turning in bed, and transferring to a chair.

The patient is fully alert and possesses intact decision-making capacity. Following an extensive multidisciplinary meeting, the patient and his wife express a strong desire to pursue a comfort-focused approach emphasizing quality of life, and they agree to hospice care. His oncologist estimates his life expectancy to be 2 to 3 months.

The patient resides in a single-story home with his 73-year-old wife. His wife suffers from severe ischemic cardiomyopathy, relies on a motorized wheelchair for mobility, and requires assistance from neighbors for household chores. They have no other family members living in the region.

Which of the following is the most appropriate disposition for this patient?

Show answer & explanation

Answer: Transfer to a skilled nursing facility with concurrent hospice services

Answer

Transfer to a skilled nursing facility with concurrent hospice services
The correct answer is transferring the patient to a skilled nursing facility with concurrent hospice services. This patient has a terminal diagnosis with a prognosis of less than 6 months and explicitly desires a comfort-focused approach, making him an appropriate candidate for hospice. Determining the correct care setting requires evaluating both his symptom burden and his caregiving needs. Because his pain is well-controlled on an oral regimen, he qualifies for routine hospice care rather than acute inpatient hospice care. However, he is completely dependent for all activities of daily living, including turning in bed and transferring. His only available caregiver is his wife, who relies on a wheelchair and cannot physically provide the heavy manual labor required for his custodial care. Routine home hospice provides intermittent nursing and aide visits but does not supply 24-hour caregivers. Therefore, discharging him home is unsafe. A skilled nursing facility provides the necessary 24-hour room, board, and custodial assistance, while the partnered hospice agency simultaneously provides specialized end-of-life care.

Step-by-Step Solution

1
Assess the patient's clinical eligibility for hospice care.
The patient has a terminal illness with an estimated life expectancy of 2 to 3 months and desires comfort care, making him fully eligible for hospice services.
Establishing hospice eligibility determines the primary framework for the care transition.
2
Determine the appropriate level of hospice care based on symptom burden.
The patient's pain is well-controlled on an oral regimen, meaning he qualifies for routine hospice care rather than crisis-level care (General Inpatient or Continuous Home Care).
Hospice care is divided into specific levels; patients without acute, refractory symptoms do not meet criteria for inpatient or continuous crisis care.
3
Evaluate the patient's functional needs against the available home caregiving capacity.
The patient requires total physical assistance (custodial care). His only caregiver is wheelchair-bound and cannot safely provide this care, making the home environment unsafe for routine discharge.
Routine home hospice does not provide 24/7 physical caregivers. If the family cannot provide custodial care, an alternative facility-based setting must be utilized.
4
Select the care setting that bridges the gap between hospice needs and physical caregiving limitations.
A skilled nursing facility (SNF) is selected to provide 24-hour room, board, and custodial care, while the hospice agency provides routine end-of-life care on-site.
This combination ensures the patient receives safe, round-the-clock physical assistance while honoring his goals of care.

Key Concept

Determining the appropriate disposition for hospice-eligible patients requires synthesizing symptom severity (to choose the correct hospice level) with the functional capacity of available home caregivers.
Question 2865Question →

An ambulatory care physician is evaluating a 64-year-old man who presents for a chronic disease management visit. He has a 10-year history of type 2 diabetes mellitus and hypertension. His daily medication regimen includes lisinopril and insulin glargine, which was added four months ago due to suboptimal glycemic control. Today, laboratory results show a hemoglobin A1c of 9.8%, compared to 8.1% four months ago. His estimated glomerular filtration rate (eGFR) is 24 mL/min/1.73 m². The patient appears hesitant, looks down, and states, 'I know my numbers are probably bad. I try my best with the insulin, but it just doesn't happen every day.' Which of the following is the most appropriate next step in counseling this patient?

Show answer & explanation

Answer: Ask the patient to describe the specific challenges he faces with his insulin regimen.

Answer

Ask the patient to describe the specific challenges he faces with his insulin regimen.
When addressing medication non-adherence, the most effective initial communication strategy is to use open-ended, non-judgmental questions. This approach invites the patient to explain their specific barriers—which could include a fear of hypoglycemia, injection pain, financial constraints, or a misunderstanding of the regimen—without feeling accused or limited by the physician's assumptions. It establishes a therapeutic alliance and is a prerequisite to adjusting the treatment plan.

Step-by-Step Solution

1
Identify the primary clinical issue presented by the patient.
The patient is exhibiting medication non-adherence to his insulin regimen and is expressing hesitation and guilt about his poor glycemic control.
Recognizing the patient's emotional state and admission of non-adherence is the first step in formulating a supportive communication strategy.
2
Determine the optimal communication framework for addressing medication non-adherence.
The physician must use open-ended, non-judgmental questions to explore the underlying barriers to adherence.
Patients may omit medications for numerous reasons (e.g., fear of hypoglycemia, injection pain, cost, misunderstanding, or depression). Open-ended inquiry prevents the physician from making incorrect assumptions.
3
Evaluate and eliminate the alternative management choices.
Reject options that escalate therapy prematurely, jump to conclusions about the cause, or use contraindicated medications (e.g., metformin in a patient with an eGFR of 24 mL/min/1.73 m²).
Safe and effective patient management requires establishing the correct 'diagnosis' for the non-adherence before altering the treatment plan.

Key Concept

When addressing medication non-adherence, physicians should employ open-ended, non-judgmental inquiry to accurately identify patient-specific barriers before altering therapeutic regimens.
Question 2866Question →

A regional public health department is investigating an unexpected cluster of a rare autoimmune encephalitis in a rural farming community. To identify potential environmental or agricultural triggers, investigators recruit 30 patients recently diagnosed with the condition. They also recruit 90 healthy individuals from the same community, intentionally ensuring the two groups have identical age and sex distributions. Investigators then conduct detailed retrospective interviews with all participants regarding their pesticide usage, water sources, and dietary habits over the preceding 24 months.

Based on the methodology described, which of the following statements are correct regarding this study design? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: The strength of the association between the environmental exposures and the disease will be estimated using an odds ratio.; The method of determining past exposures makes the investigation highly susceptible to recall bias.

Answer

The correct statements are that the association will be estimated using an odds ratio, and the investigation is highly susceptible to recall bias.
The vignette describes a case-control study, characterized by first selecting patients based on disease status (encephalitis cases vs. healthy controls) and then retrospectively assessing their exposure histories. Because the researchers artificially set the ratio of cases to controls (here, 30 cases to 90 controls), they cannot calculate incidence or prevalence. Therefore, they must use an odds ratio to estimate the strength of association. Additionally, asking participants to remember events from up to 24 months ago introduces a high risk of recall bias, as sick patients typically search their memories more thoroughly for potential causes than healthy controls.

Step-by-Step Solution

1
Identify the study design based on the vignette methodology.
The researchers start by identifying patients with the disease (cases) and a matching group without the disease (controls), then look backward in time for exposures. This is a case-control study.
Correctly identifying the study design is prerequisite to determining its statistical properties and inherent limitations.
2
Evaluate the statistical measures appropriate for a case-control study.
Case-control studies use an odds ratio to approximate relative risk. They cannot measure incidence or prevalence directly.
The proportion of cases to controls is artificially selected by the researchers (1:3 in this scenario), which removes the ability to calculate population-level incidence or prevalence rates.
3
Identify the inherent biases of the selected study design.
Because exposures are determined via retrospective interviews, the design is highly vulnerable to recall bias.
Patients suffering from a rare, severe illness often reflect more deeply on potential causes than healthy individuals, leading to unequal accuracy in reporting past exposures.
4
Analyze the incorrect statistical and epidemiological concepts in the remaining options.
Differing association strengths between male and female strata defines effect modification, not confounding. Comparing categorical exposure frequencies requires a Chi-square test, not a t-test.
Distinguishing between effect modification and confounding, as well as selecting the appropriate inferential test based on variable types, are critical competencies in interpreting medical literature.

Key Concept

Methodology, interpretation, and limitations of Case-Control Studies
Question 2867Question →

A hospital quality improvement committee is evaluating a novel automated sepsis alert protocol designed to reduce the time from triage to intravenous antibiotic administration in the emergency department. After 4 months, a preliminary analysis of 120 patients (60 pre-intervention and 60 post-intervention) shows a reduction in mean time to antibiotics of 12 minutes (p=0.08p = 0.08). The committee strongly suspects the alert protocol is clinically effective but notes there is wide variability in how nurses manually recorded the antibiotic administration times during both study periods. Assuming the novel protocol is genuinely effective, which of the following design or analytical modifications would most likely increase the study's statistical power to detect this difference in future phases?

Show answer & explanation

Answer: Implementing an automated barcode medication scanner to strictly log the exact time of antibiotic delivery

Answer

Implementing an automated barcode medication scanner to strictly log the exact time of antibiotic delivery
Statistical power (1−β1 - \beta) is the probability of correctly rejecting the null hypothesis when the alternative hypothesis is genuinely true. Power is directly influenced by four major factors: sample size, effect size, significance level (α\alpha), and the variance (or standard deviation) of the data. The vignette specifically highlights wide variability in the manual recording of medication times, which introduces random measurement error and inflates the overall variance of the continuous variable. By implementing an automated barcode scanner, the measurement error is significantly reduced. In statistical testing (such as an independent t-test), a smaller variance in the denominator yields a larger test statistic. This larger test statistic results in a smaller p-value, thereby directly increasing the statistical power of the study to detect a true difference without needing to increase the sample size.

Step-by-Step Solution

1
Identify the goal stated in the stem.
The goal is to increase statistical power (1−β1 - \beta) without necessarily increasing the sample size.
The study currently has a non-significant result (p=0.08p = 0.08) despite a suspected true effect, suggesting a potential Type II error due to inadequate power.
2
Recall the mathematical determinants of statistical power.
Power is determined by sample size (nn), effect size (difference in means), significance level (α\alpha), and standard deviation/variance (σ2\sigma^2).
Understanding these variables allows for the identification of modifications that mathematically increase power.
3
Analyze the specific problem identified in the vignette.
The vignette notes 'wide variability in how nurses manually recorded the antibiotic administration times'. This represents measurement error, which artificially inflates sample variance.
Connecting the clinical observation (manual recording variability) to the statistical formula (variance) pinpoints the source of reduced power.
4
Evaluate the options for their effect on variance and power.
Implementing an automated barcode scanner eliminates manual measurement error, thereby decreasing the sample variance. A smaller variance increases the resulting test statistic, which directly increases statistical power.
Decreasing variance is a mathematically sound method to increase the likelihood of correctly rejecting a false null hypothesis.

Key Concept

Statistical power can be increased by reducing the variance (measurement error) within the data, in addition to increasing sample size, increasing the expected effect size, or increasing the alpha level.
Question 2868Question →

Match each hospitalized patient's clinical presentation and functional status with the most appropriate post-acute care disposition.

Click a left item, then click its matching right item

Items

A 55-year-old recovering from an acute ischemic stroke with new hemiparesis. She is medically stable, cognitively intact, and demonstrates the stamina to actively participate in 3 to 4 hours of intensive, multidisciplinary physical, occupational, and speech therapy daily.
A 72-year-old recovering from a prolonged ICU course for severe acute respiratory distress syndrome. He is hemodynamically stable but remains dependent on a tracheostomy and mechanical ventilator, requiring a specialized, prolonged weaning protocol.
An 85-year-old recovering from severe sepsis complicated by profound deconditioning. He is medically stable but tires easily, tolerating a maximum of 30 to 45 minutes of physical therapy per day, and requires significant assistance with activities of daily living.
A 68-year-old who was admitted for acute osteomyelitis. He is now afebrile, medically stable, and independently ambulatory, but requires completion of a 6-week course of daily intravenous antibiotics.

Matches

Show answer & explanation

Answer

The correct pairings match each patient's medical complexity and rehabilitation tolerance to the specific admission criteria of post-acute care settings: Patient 1 matches to Inpatient Rehabilitation Facility (IRF); Patient 2 matches to Long-Term Acute Care Hospital (LTACH); Patient 3 matches to Skilled Nursing Facility (SNF); and Patient 4 matches to Home with Home Health Services.
Correct disposition requires matching patient characteristics to facility capabilities. IRFs require patients to tolerate intense therapy (minimum 3 hours/day). LTACHs serve patients with severe, complex medical conditions (e.g., prolonged mechanical ventilation) who no longer need ICU care. SNFs provide lower-intensity rehabilitation and skilled nursing for those who cannot tolerate an IRF. Home Health Services are ideal for patients who are functionally independent but require specific skilled interventions like intravenous antibiotics.

Step-by-Step Solution

1
Analyze the first patient's functional capacity and therapy needs.
The patient has a new neurologic deficit but can tolerate 3 to 4 hours of multidisciplinary therapy daily.
Identifying the patient's stamina (3+ hours/day) confirms eligibility for an Inpatient Rehabilitation Facility (IRF).
2
Evaluate the second patient's medical complexity.
The patient is hemodynamically stable but remains ventilator-dependent and requires a prolonged weaning protocol.
Patients requiring extended ventilator weaning or complex wound care who are too stable for the ICU but too complex for a standard ward or SNF belong in a Long-Term Acute Care Hospital (LTACH).
3
Assess the third patient's rehabilitation tolerance.
The patient is severely deconditioned and can only tolerate 30 to 45 minutes of physical therapy per day.
Patients who need rehabilitation but cannot meet the 3-hour daily minimum for an IRF should be placed in a Skilled Nursing Facility (SNF) for subacute, lower-intensity rehabilitation.
4
Determine the fourth patient's care requirements.
The patient is functionally independent and mobile but needs prolonged daily intravenous antibiotics.
When a patient has no ongoing skilled needs other than medication administration (e.g., IV antibiotics), Home with Home Health Services is the most appropriate and cost-effective disposition.

Key Concept

Appropriate disposition to post-acute care settings relies on synthesizing a patient's medical stability, specific nursing needs (e.g., ventilator weaning, IV antibiotics), and their physical tolerance for rehabilitation (e.g., ability to participate in 3 hours of daily therapy).
Question 2869Question →

Effective communication is a cornerstone of patient management and health education. Match each patient encounter scenario with the most appropriate initial physician communication statement or strategy.

Click a left item, then click its matching right item

Items

A patient with newly diagnosed metastatic colon cancer asks, 'Is this cancer going to kill me?' despite the family's explicit request to withhold the prognosis.
An elderly patient with multiple comorbidities is prescribed a new, complex regimen for heart failure and simply nods, stating, 'I understand the instructions perfectly.'
A patient becomes visibly angry and raises their voice regarding the two-hour delay in the waiting room before the clinic appointment.
A patient with severe alcohol use disorder states, 'I want to stop drinking, but I have failed rehab three times. I just do not have the willpower.'

Matches

Show answer & explanation

Answer

Match the ethical conflict regarding non-disclosure to assessing patient knowledge; the complex regimen to the teach-back method; the angry patient to emotional validation; and the discouraged patient with substance use disorder to affirmation.
Each matching pair represents a gold-standard communication technique tailored to a specific clinical barrier. Scenario 1 requires the 'Ask-Tell-Ask' framework to navigate family non-disclosure requests while respecting patient autonomy. Scenario 2 utilizes the 'teach-back' method, which is the most effective way to confirm health literacy and prevent medication errors. Scenario 3 relies on the NURS (Name, Understand, Respect, Support) model for empathetic communication, specifically validating the patient's frustration. Scenario 4 employs Affirmation (from the OARS core skills in motivational interviewing) to build self-efficacy in a discouraged patient.

Step-by-Step Solution

1
Analyze Scenario 1 (Family requests non-disclosure)
The physician must use the Ask-Tell-Ask framework to assess what the patient knows and wants to know before breaking bad news or bypassing the family's concerns.
Balances patient autonomy with sensitive, stepwise communication.
2
Analyze Scenario 2 (Complex regimen comprehension)
The physician must use the teach-back method to verify the patient's actual understanding.
Self-reported understanding frequently masks poor health literacy and leads to nonadherence.
3
Analyze Scenario 3 (Angry patient)
The physician should validate the patient's frustration and apologize for the systemic delay.
Naming and validating the emotion diffuses anger and preserves the physician-patient relationship.
4
Analyze Scenario 4 (Low willpower/relapse)
The physician should reframe the 'failures' as persistence and affirm the patient's resilience.
Affirmations build self-efficacy and support behavioral change in motivational interviewing.

Key Concept

Physician Communication and Patient Counseling Techniques
Question 2870Question →

A 68-year-old man is evaluated in the cardiology clinic. He has a history of rheumatic heart disease status post mechanical mitral valve replacement four years ago. He is maintained on warfarin, with a consistently stable INR between 2.5 and 3.5 over the past year. Today, his INR is 2.8. During the visit, the patient reports a 3-week history of episodic palpitations. An electrocardiogram obtained in the clinic confirms new-onset atrial fibrillation. To facilitate rhythm control, the cardiologist decides to initiate oral amiodarone. The patient's other daily medications include lisinopril and atorvastatin. Physical examination is unremarkable. Which of the following is the most appropriate next step in the management of this patient's pharmacotherapy?

Show answer & explanation

Answer: Reduce the weekly warfarin dose by 25% to 50% and recheck the INR in 1 to 2 weeks

Answer

The most appropriate next step is to preemptively reduce the weekly warfarin dose by 25% to 50% and closely monitor the INR in 1 to 2 weeks.
The most appropriate next step in monitoring and treatment evaluation for this patient is to preemptively reduce the weekly warfarin dose by 25% to 50% and recheck the INR in 1 to 2 weeks. Amiodarone is a potent inhibitor of multiple cytochrome P450 enzymes, most notably CYP2C9. Warfarin exists as a racemic mixture, and its more pharmacologically active S-enantiomer is metabolized almost entirely by CYP2C9. When amiodarone is added to a stable warfarin regimen, it reliably decreases warfarin clearance, leading to elevated serum concentrations and a supratherapeutic INR. To prevent severe bleeding complications, clinical guidelines mandate an empiric reduction of the warfarin dose by 25% to 50% at the time amiodarone is initiated, followed by close laboratory monitoring as the new steady-state is achieved.

Step-by-Step Solution

1
Identify the patient's baseline status.
The patient has a mechanical mitral valve and is optimally anticoagulated with warfarin (INR 2.8, target 2.5-3.5).
Establishing the baseline helps determine if the current therapy is effective and guides the urgency of interventions.
2
Analyze the pharmacokinetic impact of the new medication.
Initiation of amiodarone will cause potent inhibition of CYP2C9.
CYP2C9 is the primary enzyme responsible for metabolizing the highly active S-enantiomer of warfarin.
3
Determine the clinical consequence of the drug interaction.
Without intervention, warfarin clearance will decrease, leading to an accumulation of the drug, a supratherapeutic INR, and a high risk of spontaneous hemorrhage.
Anticipating the interaction is necessary for preventive patient management.
4
Select the guideline-concordant monitoring and treatment adjustment.
Empirically reduce the maintenance warfarin dose by 25% to 50% upon starting amiodarone, followed by an INR check in 1 to 2 weeks.
This preemptive strategy safely maintains the INR within the therapeutic window during the transition phase.

Key Concept

When amiodarone is initiated in a patient stabilized on warfarin, the warfarin dose must be preemptively reduced by 25% to 50% due to amiodarone's potent inhibition of CYP2C9, which significantly decreases warfarin clearance.
Estimated Time:1m 15s
Question 2871Question →

A 45-year-old woman with severe, uncontrolled asthma asks her physician about a new monoclonal antibody she recently heard about. The physician reviews the pivotal phase III randomized, double-blind, placebo-controlled trial for the drug. The trial evaluated the incidence of severe asthma exacerbations requiring hospitalization over a 12-month period.

The study results are summarized in the following table:

GroupTotal PatientsSevere Exacerbations
Monoclonal Antibody2,5002,500150150
Placebo2,5002,500400400

Based on these trial results, which of the following is the most accurate statement regarding the drug's efficacy that the physician can share with the patient?

Show answer & explanation

Answer: For every 1010 patients treated with this drug for one year, one severe asthma exacerbation is prevented.

Answer

For every 10 patients treated with this drug for one year, one severe asthma exacerbation is prevented.
The Number Needed to Treat (NNT) is calculated as 1ARR\frac{1}{\text{ARR}}. The Absolute Risk Reduction (ARR) is the Control Event Rate (CER) minus the Experimental Event Rate (EER). Here, CER=4002500=0.16\text{CER} = \frac{400}{2500} = 0.16 and EER=1502500=0.06\text{EER} = \frac{150}{2500} = 0.06. Thus, ARR=0.16−0.06=0.10\text{ARR} = 0.16 - 0.06 = 0.10. The NNT is 10.10=10\frac{1}{0.10} = 10, meaning 1010 patients must be treated for one year to prevent one severe exacerbation.

Step-by-Step Solution

1
Calculate the Control Event Rate (CER).
CER = 4002500=0.16\frac{400}{2500} = 0.16 (16%16\%)
To determine the baseline risk of exacerbations in the untreated (placebo) population.
2
Calculate the Experimental Event Rate (EER).
EER = 1502500=0.06\frac{150}{2500} = 0.06 (6%6\%)
To determine the risk of exacerbations in the population receiving the monoclonal antibody.
3
Calculate the Absolute Risk Reduction (ARR).
ARR = CER−EER=0.16−0.06=0.10\text{CER} - \text{EER} = 0.16 - 0.06 = 0.10 (10%10\%)
To find the absolute difference in risk between the two groups, which is required for determining the Number Needed to Treat.
4
Calculate the Number Needed to Treat (NNT).
NNT = 1ARR=10.10=10\frac{1}{\text{ARR}} = \frac{1}{0.10} = 10
NNT represents the number of patients who must be treated to prevent one additional adverse event.

Key Concept

Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) are measures of absolute effect that provide clinical context for a treatment's benefit.
Question 2872Question →

Investigators at an academic research institute are evaluating the real-world safety of two oral anticoagulants in patients with nonvalvular atrial fibrillation. To accomplish this, they extract data from a large national insurance claims database spanning the last five years. The researchers restrict their analysis to patients who have just initiated therapy (a new-user design) and follow them forward in the database to compare the incidence of major gastrointestinal bleeding between the two drug groups. To adjust for differences in baseline characteristics, they utilize high-dimensional propensity score matching based on 150 demographic and clinical covariates derived from the available billing codes. Which of the following statements regarding the methodological characteristics and limitations of this study design are correct?

Select all that apply

Show answer & explanation

Answer: The study remains susceptible to residual confounding from clinical variables not routinely captured in billing records.; The implementation of a new-user design helps minimize survivor bias compared to including prevalent users.; The reliance on administrative data introduces a risk of information bias through potential misclassification of clinical outcomes.

Answer

The correct methodological characteristics include the study's susceptibility to residual confounding from unmeasured variables, the benefit of the new-user design in minimizing survivor bias, and the risk of information bias introduced by the reliance on administrative claims data.
The scenario describes a retrospective cohort study utilizing administrative data. In this design, patients are defined by their exposure status and followed forward for an outcome, which permits the direct calculation of incidence rates and relative risks. Using a new-user design is a methodological strength that minimizes survivor bias (healthy user bias) by ensuring patients who experienced early adverse events are not excluded. However, the study has inherent limitations: reliance on billing codes introduces the risk of information bias (misclassification of the outcome or comorbidities), and despite rigorous propensity score matching, observational studies remain inherently vulnerable to residual confounding from unmeasured variables.

Step-by-Step Solution

1
Identify the fundamental study design described in the vignette.
The scenario describes a retrospective cohort study using an administrative claims database.
Patients are identified based on exposure (drug initiation) and followed forward in the dataset to observe the outcome (gastrointestinal bleeding).
2
Evaluate the properties of propensity score matching (PSM).
PSM is identified as a robust method to control for confounding, but only for variables that are explicitly measured and included in the model.
Recognizing that PSM does not mimic the unmeasured confounding control provided by true randomization is critical for interpreting real-world evidence.
3
Analyze the impact of a new-user design versus a prevalent-user design.
A new-user design ensures all patients are captured from the moment of first exposure.
This mitigates survivor bias and the 'depletion of susceptibles' phenomenon, where patients who tolerate a drug long-term look artificially healthier than a newly initiated comparison group.
4
Determine the inherent limitations of the data source.
Administrative claims data is identified as prone to coding errors and omissions.
Because the data was generated for billing rather than research, misclassification of outcomes (information bias) is a persistent threat to validity.

Key Concept

Methodological strengths and limitations of observational cohort studies using administrative data and propensity score matching.
Question 2873Question →

A 58-year-old man with a history of alcohol-related cirrhosis is evaluated in the clinic for a follow-up visit. One week ago, he presented with tense ascites and newly developed bilateral 2+ pitting lower extremity edema. At that time, a sodium-restricted diet was reinforced, and he was prescribed spironolactone 100 mg100\text{ mg} and furosemide 40 mg40\text{ mg} daily. Today, the patient reports feeling generally well but notes increased thirst and a dry mouth. He denies abdominal pain, fever, confusion, or gastrointestinal bleeding. His weight has decreased by 7 kg7\text{ kg} (15.4 lbs15.4\text{ lbs}) since his visit one week ago. Blood pressure is 102/64 mmHg102/64\text{ mmHg} and pulse is 92/min92/\text{min}. Physical examination shows mild residual abdominal distention with a positive fluid wave, but his lower extremity edema has completely resolved.

Laboratory results obtained today are compared to those from one week ago:

Laboratory TestOne Week AgoToday
Sodium136 mEq/L136\text{ mEq/L}132 mEq/L132\text{ mEq/L}
Potassium4.2 mEq/L4.2\text{ mEq/L}4.8 mEq/L4.8\text{ mEq/L}
Blood urea nitrogen18 mg/dL18\text{ mg/dL}48 mg/dL48\text{ mg/dL}
Creatinine0.8 mg/dL0.8\text{ mg/dL}1.9 mg/dL1.9\text{ mg/dL}

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Discontinue both spironolactone and furosemide

Answer

The most appropriate next step is to discontinue both spironolactone and furosemide.
This patient has developed a severe acute kidney injury (AKI) secondary to overly rapid diuresis. While a weight loss of 1 kg/day1\text{ kg/day} can be safe when peripheral edema is present, his edema has now completely resolved. Continued aggressive diuresis has mobilized fluid from the intravascular space, leading to hypovolemia, a markedly elevated blood urea nitrogen level, and a serum creatinine that has more than doubled from baseline. In a patient with decompensated cirrhosis, any significant AKI requires the immediate discontinuation of all diuretics (both spironolactone and furosemide) and any other nephrotoxic medications to restore renal perfusion and prevent the development of hepatorenal syndrome.

Step-by-Step Solution

1
Analyze the patient's clinical signs and weight trend.
The patient lost 7 kg7\text{ kg} in 77 days. While 1 kg/day1\text{ kg/day} is acceptable when peripheral edema is present, the edema has completely resolved, leading to intravascular volume contraction (evidenced by dry mouth and borderline blood pressure).
Tracking fluid compartments is essential in cirrhosis management to ensure diuresis targets extracellular fluid and not the intravascular space.
2
Interpret the comparative laboratory results.
The BUN has risen significantly, and the serum creatinine has more than doubled from 0.8 mg/dL0.8\text{ mg/dL} to 1.9 mg/dL1.9\text{ mg/dL}.
These findings confirm a diagnosis of prerenal acute kidney injury (AKI) secondary to aggressive diuresis.
3
Determine the necessary treatment modification based on the AKI diagnosis.
Both spironolactone and furosemide must be held immediately.
Continuing diuretics during an episode of AKI in a cirrhotic patient greatly increases the risk of progression to life-threatening hepatorenal syndrome.

Key Concept

Patients with cirrhosis and ascites who develop acute kidney injury (AKI) during diuresis must have all diuretic medications immediately discontinued to prevent progression to hepatorenal syndrome.
Question 2874Question →

A 4848-year-old woman comes to the clinic for a routine health maintenance examination. She feels well and has no specific complaints. Her past medical history is significant for a total abdominal hysterectomy for symptomatic benign uterine fibroids 44 years ago. She does not use tobacco, alcohol, or illicit drugs. Her family history is unremarkable. Her blood pressure is 118/76118/76 mm Hg, pulse is 7272/min, and BMI is 2424 kg/m 2^2. Her last screening mammogram was performed 1111 months ago and was normal. She has never undergone screening for colorectal cancer. Which of the following is the most appropriate next step in the preventive care of this patient?

Show answer & explanation

Answer: Referral for screening colonoscopy

Answer

Referral for screening colonoscopy is the most appropriate next step, as average-risk adults should begin colorectal cancer screening at age 45.
The correct answer is referral for screening colonoscopy. According to the United States Preventive Services Task Force (USPSTF), screening for colorectal cancer is recommended for all average-risk adults starting at age 45 and continuing until age 75. Because this patient is 48 years old and has never undergone screening, initiating colorectal cancer screening (via colonoscopy, fecal immunochemical testing, or another recommended modality) is the single most appropriate next step in her preventive care.

Step-by-Step Solution

1
Identify the patient's demographic risk profile and surgical history.
The patient is a 48-year-old female with no history of tobacco use and a past surgical history of a total hysterectomy for benign disease.
Age, sex, surgical history, and social habits dictate the indications for specific preventive screening tests.
2
Evaluate the patient's existing screening records against current guidelines.
She had a normal mammogram 11 months ago (due every 2 years). She had a total hysterectomy for benign fibroids (cervical cancer screening is no longer indicated).
To rule out interventions that are either premature or permanently contraindicated based on her medical history.
3
Identify missing age-appropriate screening interventions.
The patient has never been screened for colorectal cancer, which is universally recommended starting at age 45.
To select the single most appropriate and currently indicated preventive care step.

Key Concept

Average-risk colorectal cancer screening guidelines and indications for discontinuing cervical cancer screening.
Question 2875Question →

During a scheduled home hospice assessment, a 73-year-old man with metastatic pancreatic adenocarcinoma is found to be acutely confused and highly agitated. According to his spouse, the behavioral changes started abruptly 36 hours ago. The patient has been picking continuously at his bedsheets, experiencing visual hallucinations, and groaning loudly. His baseline pain regimen consists of a transdermal fentanyl patch and scheduled oral morphine, alongside daily oral senna. Prior to this episode, his pain was reported as well-controlled and he was resting comfortably. On examination, the patient is restless and disoriented to time, place, and person. Vital signs are within normal limits for his condition. Abdominal examination reveals a firm, distended midline mass extending just below the umbilicus; the patient grimaces when this specific area is gently palpated. Bowel sounds are normoactive in all four quadrants. Review of his daily symptom log indicates he has not voided urine or had a bowel movement in the past two days. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Insert an indwelling urethral catheter

Answer

Insert an indwelling urethral catheter to decompress the bladder and resolve the underlying cause of the agitation.
The correct response addresses the direct, reversible cause of this patient's hyperactive delirium. Acute urinary retention is a frequent complication in patients receiving scheduled opioids and anticholinergic medications. It presents as severe agitation, confusion, and abdominal discomfort. The physical examination finding of a firm, tender midline mass extending below the umbilicus is the classic presentation of a massively distended bladder. In palliative and end-of-life care, the standard protocol for sudden delirium is to first assess for and treat easily reversible causes (e.g., urinary retention, fecal impaction, hypoxia) before resorting to antipsychotics. Inserting an indwelling urethral catheter will drain the bladder, instantly relieving the physical distress and subsequently resolving the secondary delirium.

Step-by-Step Solution

1
Analyze the patient's acute presentation.
The patient has new-onset hyperactive delirium (agitation, hallucinations, disorientation) over the past 36 hours.
Identifying the primary clinical syndrome is necessary to formulate a targeted differential diagnosis in a hospice setting.
2
Correlate physical examination findings with the patient's history.
The presence of a firm, tender midline mass below the umbilicus combined with two days of anuria strongly indicates acute urinary retention.
Physical examination often reveals the reversible etiology behind sudden behavioral changes in palliative patients.
3
Select the most appropriate, least invasive intervention to address the root cause.
Catheterizing the bladder will provide immediate relief of the retention.
In palliative care, identifying and reversing easily treatable causes of distress (like full bladders or impacted bowels) must precede the use of pharmacologic sedation.

Key Concept

Evaluation and management of reversible causes of delirium, such as urinary retention, must be prioritized before initiating antipsychotics or palliative sedation in hospice patients.
Question 2876Question →

A 4545-year-old woman visits her primary care physician for a routine wellness examination. She is generally healthy but reports a strong family history of a specific autoimmune thyroid disorder. The physician explains that based on her demographic profile and family history, her pretest probability of having the subclinical form of this disorder is 20%20\%. They discuss a newly approved serum biomarker assay that detects this condition. Clinical validation studies demonstrate that this assay has a sensitivity of 75%75\% and a specificity of 90%90\%. The patient opts to proceed with the screening, and the laboratory reports a positive result. Which of the following is the approximate probability that this patient truly has the subclinical autoimmune disorder?

Show answer & explanation

Answer: 65%65\%

Answer

65%65\%
The correct answer is 65%65\%. The question requires determining the post-test probability of disease given a positive test result, which is the Positive Predictive Value (PPV). The PPV depends on the test's sensitivity, specificity, and the pretest probability (prevalence) of the condition in the patient's demographic. This can be calculated easily using a hypothetical 100100-person population model:

1. Disease distribution: Based on a 20%20\% pretest probability, 2020 people truly have the disease and 8080 do not.
2. True Positives (TP): Sensitivity is 75%75\%. Out of 2020 people with the disease, 1515 will correctly test positive (20×0.75=1520 \times 0.75 = 15).
3. False Positives (FP): Specificity is 90%90\%, meaning the false positive rate is 10%10\%. Out of 8080 people without the disease, 88 will falsely test positive (80×0.10=880 \times 0.10 = 8).
4. PPV Calculation: The total number of positive results is 2323 (15 TP+8 FP15 \text{ TP} + 8 \text{ FP}). The probability that a positive result is a true positive is 15/23≈0.652115 / 23 \approx 0.6521, or approximately 65%65\%.

Step-by-Step Solution

1
Set up a hypothetical population (e.g., 100100 patients) to determine the distribution of true disease based on the pretest probability.
With a 20%20\% pretest probability, 2020 patients have the disease and 8080 patients do not have the disease.
Creating a standard population model makes it easier to visualize and calculate true positives and false positives without complex algebraic formulas.
2
Calculate the number of true positive results using the test's sensitivity.
Sensitivity is 75%75\%. Therefore, 75%75\% of the 2020 patients with the disease will test positive (20×0.75=1520 \times 0.75 = 15 true positives).
Sensitivity measures the proportion of actual positives that are correctly identified as such.
3
Calculate the number of false positive results using the test's specificity.
Specificity is 90%90\%, meaning the false positive rate is 10%10\%. Therefore, 10%10\% of the 8080 patients without the disease will incorrectly test positive (80×0.10=880 \times 0.10 = 8 false positives).
Specificity measures the proportion of actual negatives that are correctly identified. The remainder (1−Specificity1 - \text{Specificity}) represents the false positive rate.
4
Calculate the Positive Predictive Value (PPV), which is the probability of having the disease given a positive test.
PPV=True PositivesTotal Positives=1515+8=1523≈0.652\text{PPV} = \frac{\text{True Positives}}{\text{Total Positives}} = \frac{15}{15 + 8} = \frac{15}{23} \approx 0.652, or 65%65\%.
PPV directly answers the clinical question: 'Given a positive test result, what is the actual probability that my patient has the disease?'

Key Concept

Positive Predictive Value (PPV) calculation and the effect of pretest probability on post-test outcomes.
Question 2877Question →

A 24-year-old woman with type 1 diabetes mellitus is admitted to the intensive care unit with diabetic ketoacidosis. She is initiated on appropriate intravenous normal saline, potassium replacement, and a continuous regular insulin infusion. Her initial blood glucose is 550 mg/dL550 \text{ mg/dL} and anion gap is 24 mEq/L24 \text{ mEq/L}.

Arrange the following monitoring and therapeutic steps in the correct chronological sequence required to safely transition this patient off intravenous insulin.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence involves first adding dextrose when glucose falls to prevent hypoglycemia, followed by confirming anion gap closure. Once the gap is closed, subcutaneous insulin is administered, and finally, the IV insulin is discontinued after a 1-to-2-hour overlap.
The correct sequence prioritizes maintaining the insulin infusion to close the anion gap while managing the dropping glucose levels by adding dextrose. Once the gap closes, a safe transition requires overlapping the new subcutaneous insulin dose with the IV drip for 11 to 22 hours to prevent rebound ketoacidosis.

Step-by-Step Solution

1
Monitor hourly blood glucose and add 5%5\% dextrose to IV fluids when glucose reaches 200 mg/dL200 \text{ mg/dL}.
Prevents hypoglycemia while allowing insulin to continue.
Insulin infusion must be continued to clear ketones, even if blood glucose normalizes rapidly.
2
Monitor basic metabolic panel every 22 to 44 hours until the anion gap is ≤12 mEq/L\leq 12 \text{ mEq/L} and venous pH is >7.3> 7.3.
Confirms resolution of diabetic ketoacidosis.
Anion gap closure indicates that ketone production (lipolysis) has been successfully suppressed.
3
Administer subcutaneous basal insulin when the patient can tolerate oral intake.
Prepares the patient for removal of the IV insulin drip.
Subcutaneous long-acting insulin has a delayed onset of action and provides baseline coverage.
4
Stop the IV insulin infusion 11 to 22 hours after giving the subcutaneous dose.
Safely completes the transition to maintenance therapy.
Overlapping the two insulin routes prevents a sudden drop in insulin levels that could precipitate rebound DKA.

Key Concept

Resolution of DKA requires continuous insulin until the anion gap closes; dextrose is added to prevent hypoglycemia, and subcutaneous insulin must overlap with the IV infusion for 11 to 22 hours before discontinuation.
Question 2878Question →

A medical research center is reviewing proposals for several new clinical and epidemiological investigations. Match each proposed clinical research scenario with the most appropriate epidemiological study design.

Click a left item, then click its matching right item

Items

Following a group of factory workers exposed to silica dust and a group of unexposed workers over a 20-year period to compare the incidence of pulmonary fibrosis.
Comparing two antiemetic regimens by assigning patients to receive regimen A during their first chemotherapy cycle and regimen B during their second cycle, separated by a washout period.
Assessing the simultaneous prevalence of e-cigarette use and self-reported asthma symptoms at a single point in time among high school students.
Investigating the association between prior exposure to a specific industrial solvent and the development of a rare form of hepatic angiosarcoma by comparing affected patients to healthy matched individuals.

Matches

Show answer & explanation

Answer

The correct matches are: Factory workers to Prospective cohort study, Antiemetic regimens to Crossover trial, Prevalence survey to Cross-sectional study, and Rare angiosarcoma to Case-control study.
Each scenario maps to a unique study design based on its methodology. Cohort studies follow exposed/unexposed groups over time. Crossover trials give sequential treatments to the same patients. Cross-sectional studies take a 'snapshot' of prevalence. Case-control studies are optimal for rare diseases by starting with known cases and comparing them to healthy controls.

Step-by-Step Solution

1
Analyze the starting point and timing of the factory worker scenario.
The study groups participants by exposure (silica) and follows them forward in time to measure disease incidence.
Grouping by exposure and tracking forward identifies a prospective cohort study.
2
Analyze the treatment sequence in the antiemetic regimen scenario.
Patients receive multiple sequential treatments with a washout period, acting as their own controls.
Sequential treatment of the same subjects with a washout period is the defining feature of a crossover trial.
3
Evaluate the timing of data collection in the high school survey scenario.
Exposure and outcome are measured simultaneously at a single point in time to assess prevalence.
Simultaneous measurement without follow-up identifies a cross-sectional study.
4
Assess the outcome frequency in the industrial solvent scenario.
The outcome is a rare cancer, and participants are grouped by disease status first.
Grouping by rare disease status and looking retrospectively for exposure characterizes a case-control study.

Key Concept

Selection of epidemiological study designs based on exposure/outcome timing, outcome rarity, and treatment sequencing.
Question 2879Question →

A 42-year-old man presents to the primary care clinic for counseling regarding his alcohol use. He exhibits varying levels of insight and readiness to change over a series of visits. Based on the Transtheoretical Model of Change and the principles of Motivational Interviewing, match each of the patient's statements with the most appropriate and effective physician counseling response.

Click a left item, then click its matching right item

Items

"My wife is overreacting about my drinking. I only have a few drinks to unwind after a stressful day, which is completely normal for someone in my high-pressure profession."
"I see that my blood pressure is elevated and I know the alcohol isn't helping, but the idea of stopping completely just seems impossible right now with my current work stress."
"I poured out my liquor cabinet yesterday and I plan to start abstaining this weekend, though I am deeply worried about how I will handle the physical cravings."
"It has been six months since my last drink. I feel fantastic, but the upcoming holiday season and being around my family has me feeling very anxious."

Matches

Show answer & explanation

Answer

Match the Precontemplation statement to the request for permission to discuss health effects; the Contemplation statement to the reflection of ambivalence; the Preparation statement to medical action planning; and the Maintenance statement to relapse prevention strategizing.
Effective patient counseling for behavioral change requires matching the physician's intervention to the patient's readiness stage as defined by the Transtheoretical Model. For Precontemplation, physicians should build rapport and ask permission. For Contemplation, physicians should explore ambivalence and elicit change talk. For Preparation, physicians help formulate specific, safe action plans. For Maintenance, physicians focus on identifying high-risk triggers and preventing relapse.

Step-by-Step Solution

1
Analyze the first patient statement.
The patient denies having a problem and blames his wife, indicating the Precontemplation stage of change.
Identifying the stage of change dictates the counseling technique; precontemplative patients require rapport building and asking permission to share information, rather than direct advice.
2
Analyze the second patient statement.
The patient recognizes harm (elevated blood pressure) but feels unable to stop, indicating the Contemplation stage.
Contemplative patients have ambivalence; the physician must reflect both sides of the ambivalence to help the patient move toward a decision without creating resistance.
3
Analyze the third patient statement.
The patient has taken a preliminary step (pouring out liquor) and set a date, indicating the Preparation stage.
Patients in preparation need assistance with concrete planning and barrier mitigation, such as safely managing physical withdrawal.
4
Analyze the fourth patient statement.
The patient has been abstinent for six months but anticipates a high-risk situation, indicating the Maintenance stage.
Maintenance counseling focuses on relapse prevention, self-efficacy reinforcement, and coping skill development for specific triggers.

Key Concept

Applying the Transtheoretical Model of Change and Motivational Interviewing techniques in patient counseling.
Question 2880Question →

A 32-year-old woman is evaluated in the clinic for fatigue and pica. Laboratory studies confirm severe iron deficiency anemia with a hemoglobin of 8.28.2 g/dL and a ferritin of 66 ng/mL. The physician initiates treatment with daily oral ferrous sulfate. Arrange the following monitoring and treatment evaluation steps in the correct chronological sequence from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: evaluate reticulocyte count (peaks at 1-2 weeks), measure hemoglobin concentration (normalizes at 4-8 weeks), measure serum ferritin (normalizes 3-6 months after hemoglobin correction), and finally discontinue oral ferrous sulfate therapy.
Following the initiation of oral iron therapy for iron deficiency anemia, the body prioritizes the creation of new red blood cells to address the oxygen-carrying deficit. The very first measurable response is an increase in immature red blood cells (reticulocytes), which peaks at 1 to 2 weeks. Following this reticulocytosis, the overall hemoglobin level slowly rises and typically normalizes within 4 to 8 weeks. Once the functional anemia is completely corrected, continued iron absorption goes toward replenishing the body's depleted iron stores, a process reflected by rising serum ferritin. This repletion phase takes 3 to 6 months of continuous therapy. Therefore, ferritin is measured last to confirm stores are full, after which the iron therapy can be safely discontinued.

Step-by-Step Solution

1
Identify the immediate physiologic response to iron supplementation.
Reticulocytosis occurs first.
The bone marrow immediately uses the newly available iron to rapidly produce new red blood cells, leading to a reticulocyte peak in 7 to 10 days.
2
Determine when the mature red blood cell mass normalizes.
Hemoglobin normalizes next.
As reticulocytes mature and accumulate in the peripheral blood, the total hemoglobin concentration rises, typically normalizing within 4 to 8 weeks.
3
Establish when total body iron reserves are adequately rebuilt.
Ferritin normalizes last.
Only after the body's functional iron needs (hemoglobin) are met does it begin to store excess iron as ferritin. This repletion phase takes an additional 3 to 6 months of continuous therapy.
4
Determine the appropriate endpoint of treatment.
Discontinue iron therapy.
Therapy is considered complete and can be stopped only when both the active anemia is resolved and the iron stores are fully replenished.

Key Concept

Chronological sequence of laboratory monitoring and treatment endpoints in iron deficiency anemia
PreviousPage 144 / 237Next